David M. Slovik

2.9k total citations · 1 hit paper
24 papers, 2.2k citations indexed

About

David M. Slovik is a scholar working on Orthopedics and Sports Medicine, Oncology and Nephrology. According to data from OpenAlex, David M. Slovik has authored 24 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Orthopedics and Sports Medicine, 9 papers in Oncology and 8 papers in Nephrology. Recurrent topics in David M. Slovik's work include Bone health and osteoporosis research (10 papers), Bone health and treatments (9 papers) and Parathyroid Disorders and Treatments (8 papers). David M. Slovik is often cited by papers focused on Bone health and osteoporosis research (10 papers), Bone health and treatments (9 papers) and Parathyroid Disorders and Treatments (8 papers). David M. Slovik collaborates with scholars based in United States, United Kingdom and Netherlands. David M. Slovik's co-authors include Robert M. Neer, Murray J. Favus, John T. Potts, Thomas L. Kelly, John S. Adams, Michael F. Holick, Samuel H. Doppelt, Daniel I. Rosenthal, David Schoenfeld and J. Reeve and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

David M. Slovik

24 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.

1980 462 citations J. Reeve, Pierre J. Meunier et al. BMJ profile →

Peers

Countries citing papers authored by David M. Slovik

Since Specialization

Citations

This map shows the geographic impact of David M. Slovik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Slovik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Slovik more than expected).

Fields of papers citing papers by David M. Slovik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Slovik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Slovik. The network helps show where David M. Slovik may publish in the future.

Co-authorship network of co-authors of David M. Slovik

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Slovik. A scholar is included among the top collaborators of David M. Slovik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Slovik. David M. Slovik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autoimmune Hypocalciuric Hypercalcemia Unresponsive to Glucocorticoid Therapy in a Patient with Blocking Autoantibodies against the Calcium-Sensing Receptor 2010 ·The Journal of Clinical Endocrinology & Metabolism ·J. Carl Pallais, E. Helen Kemp, Clemens Bergwitz, Lakshmi Kantham, David M. Slovik, Anthony P. Weetman, Edward M. Brown	20
2	Exercise in Rehabilitation Medicine 2005 ·Medical Entomology and Zoology ·Walter R. Frontera, David M. Slovik, David M. Dawson	57
3	Acquired Hypocalciuric Hypercalcemia Due to Autoantibodies against the Calcium-Sensing Receptor 2004 ·New England Journal of Medicine ·J. Carl Pallais, Olga Kifor, Yi‐Bin Chen, David M. Slovik, Edward M. Brown	70
4	Activation and inhibition of mast cells degranulation affect their morphometric parameters 2000 ·Life Sciences ·Francesca Levi‐Schaffer, David M. Slovik, (unknown), Dalia Pickholtz, Elka Touítou	23
5	[Rational use of albumin]. 2000 ·PubMed ·Emanuel Sikuler, (unknown), S Mor-Yosef, (unknown), David M. Slovik, (unknown), Günhan Gürman	2
6	CURRENT AND INVESTIGATIONAL APPROACHES FOR REVERSING ESTABLISHED OSTEOPOROSIS 1994 ·Rheumatic Disease Clinics of North America ·Donald B. Kimmel, David M. Slovik, Nancy E. Lane	20
7	Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 1994 ·The Endocrinologist ·Murray J. Favus, David M. Slovik	104
8	Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol 1993 ·Osteoporosis International ·(unknown), David M. Slovik, Margaret Daly, (unknown), S R Nussbaum	70
9	Calibration and standardization of bone mineral densitometers 1989 ·Journal of Bone and Mineral Research ·Thomas L. Kelly, David M. Slovik, Robert M. Neer	48
10	Quantitative Digital RadiographyVersusDual Photon Absorptiometry of the Lumbar Spine* 1988 ·The Journal of Clinical Endocrinology & Metabolism ·Thomas L. Kelly, David M. Slovik, David Schoenfeld, Robert M. Neer	172
11	Changes in serum levels of type I and III procollagen extension peptides during infusion of human parathyroid hormone fragment (1–34) 1988 ·Journal of Bone and Mineral Research ·Lee S. Simon, David M. Slovik, Robert M. Neer, Stephen M. Krane	13
12	Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D 1986 ·Journal of Bone and Mineral Research ·David M. Slovik, Daniel I. Rosenthal, Samuel H. Doppelt, John T. Potts, (unknown), Julie A. Campbell, Robert M. Neer	262
13	Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens 1986 ·Bone ·J. Reeve, R. Hesp, M Audran, J C Rénier, David M. Slovik, (unknown), C Edouard, P. J. Meunier	4
14	Quantitative Computed Tomography for Spinal Density Measurement Factors Affecting Precision 1985 ·Investigative Radiology ·Daniel I. Rosenthal, Marie A. Ganott, Grace Wyshak, David M. Slovik, Samuel H. Doppelt, Robert M. Neer	62
15	Gut-mediated hypercalcemia in rabbits bearing VX2 carcinoma: new mechanism for tumor-induced hypercalcemia. 1982 ·Proceedings of the National Academy of Sciences ·Samuel H. Doppelt, David M. Slovik, Robert M. Neer, James Nolan, Randall M. Zusman, John T. Potts	19
16	Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: The influence of human parathyroid fragment (hPTH 1-34) therapy 1981 ·Metabolic Bone Disease and Related Research ·J. Reeve, M. Arlot, M Bernat, S Charhon, C Edouard, David M. Slovik, F. J. F. E. Vismans, Pierre J. Meunier	42
17	Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. breakdown → 1980 ·BMJ ·J. Reeve, Pierre J. Meunier, J. A. Parsons, M Bernat, O. L. M. Bijvoet, P Courpron, C Edouard, L. Klenerman, Robert M. Neer, J C Rénier, David M. Slovik, F. J. F. E. Vismans, John T. Potts	462
18	A comparison between the balance method and radiotracer methods for measuring calcium absorption in treated and untreated patients with osteoporosis 1980 ·Metabolic Bone Disease and Related Research ·J. Reeve, O. L. M. Bijvoet, Robert M. Neer, David M. Slovik, M. Tellez, F. J. F. E. Vismans, G.D. Zanelli	10
19	PARATHYROID HORMONE AND 25‐HYDROXYVITAMIN D LEVELS IN GLUCOCORTICOID‐TREATED PATIENTS 1980 ·Clinical Endocrinology ·David M. Slovik, Robert M. Neer, John L. Ohman, Francis C. Lowell, M. B. Clark, G V Segre, John T. Potts	49
20	Secretion by glucagonomas of a possible glucagon precursor. 1977 ·Journal of Clinical Investigation ·Gordon C. Weir, Edward S. Horton, T. T. Aoki, David M. Slovik, Jonathan B. Jaspan, A. H. Rubenstein	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact